<DOC>
	<DOC>NCT01044836</DOC>
	<brief_summary>The purpose of this study is compare the safety and pharmacokinetic characteristics of HD203 with those of etanercept after subcutaneous injection in healthy male volunteers.</brief_summary>
	<brief_title>Safety and Pharmacokinetic Characteristics of HD203 in Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>20 to 40 years of healthy volunteers</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>